Atorvastatin‐induced intracerebral hemorrhage is inhibited by berberine in zebrafish
Journal of Applied Toxicology · 2024
DOI: 10.1002/jat.4614 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Toxicology, 2024. Verfasst von Xin-Yan Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biotechnology of Antibiotics, the National Health Commission (NHC), Beijing Key Laboratory of Antimicrobial Agents, Institute of Me…. Hauptthemen laut MEDLINE: Zebrafish, Atorvastatin, Cerebral Hemorrhage, Berberine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: CAMS Innovation Fund for Medical Sciences, Foundation for Innovative Research Groups of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Intracerebral hemorrhage (ICH), for which there are currently no effective preventive or treatment methods, has a very high fatality rate. Statins, such as atorvastatin (ATV), are the first‐line drugs for regulating blood lipids and treating hyperlipidemia‐related cardiovascular diseases. However, ATV‐associated ICH has been reported, although its incidence is rare. In this study, we aimed to investigate the protective action and mechanisms of berberine (BBR) against ATV‐induced brain hemorrhage. We established an ICH model in zebrafish induced by ATV (2 μM) and demonstrated the effects of BBR (10, 50, and 100 μM) on ICH via protecting the vascular network using hemocyte staining and three transgenic zebrafish. BBR was found to reduce brain inflammation and locomotion injury in ICH‐zebrafish. Mechanism research showed that ATV increased the levels of VE‐cadherin and occludin proteins but disturbed their localization at the cell membrane by abnormal phosphorylation, which decreased the number of intercellular junctions between vascular endothelial cells (VECs), disrupting the integrity of vascular walls. BBR reversed the effects of ATV by promoting autophagic degradation of phosphorylated VE‐cadherin and occludin in ATV‐induced VECs examined by co‐immunoprecipitation (co‐IP). These findings provide crucial insights into understanding the BBR mechanisms involved in the maintenance of vascular integrity and in mitigating adverse reactions to ATV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Biotechnology of Antibiotics, the National Health Commission (NHC), Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking…
ORCID-Profile: Xin-Yan Liu
Förderung
- CAMS Innovation Fund for Medical Sciences
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China
Zitieren
APA
Liu, X. Y., Chen, B., Zhang, R., Zhang, M. Q., Ma, Y. Y., Han, Y., Jiang, J. D., & Zhang, J. P. (2024). Atorvastatin‐induced intracerebral hemorrhage is inhibited by berberine in zebrafish. Journal of Applied Toxicology. https://doi.org/10.1002/jat.4614
Vancouver
Liu XY, Chen B, Zhang R, Zhang MQ, Ma YY, Han Y, et al. Atorvastatin‐induced intracerebral hemorrhage is inhibited by berberine in zebrafish. Journal of Applied Toxicology. 2024. doi:10.1002/jat.4614
BibTeX
@article{Liu2024,
author = {Liu, Xin-Yan and Chen, Bo and Zhang, Rui and Zhang, Miao-Qing and Ma, Yuan-Yuan and Han, Ying and Jiang, Jian-Dong and Zhang, Jing-Pu},
title = {Atorvastatin‐induced intracerebral hemorrhage is inhibited by berberine in zebrafish},
journal = {Journal of Applied Toxicology},
year = {2024},
doi = {10.1002/jat.4614}
}
EUVIMED